Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients

International Journal of Immunogenetics

Volumn 37, Issue 4, 2010, Pages 225-231

  Paradowska Gorycka, A ^a   Trefler, J ^a   Maciejewska Stelmach, J ^b   Lacki J K ^c  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

^b Department of Rheumatology   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; GENETIC POLYMORPHISM; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; POLAND; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 78651086221     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00913.x     Document Type: Article

References (38)

1. Arend, W.P. (2001) Physiology of cytokine pathways in rheumatoid arthritis. Arthritis and Rheumatism, 45, 101.
2. Asadullah, K., Sterry, W. & Volk, H.D. (2003) Interleukin-10 therapy-review of a new approach. Pharmacological Reviews, 55, 241.
3. Ates, O., Hatemi, G., Hamuryudan, V. & Topal-Sarikaya, A. (2008) Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clinical Rheumatology, 27, 1243.
4. Bali, D., Gourley, S., Kostyu, D.D., Goel, N., Bruce, I., Bell, A. et al. (1999) Genetic analysis of multiplex rheumatoid arthritis families. Genes and Immunity, 1, 28.
5. Bingham, C.O. (2002) The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. Journal of Rheumatology, 29(Suppl. 65), 3.
6. Bowes, J. & Barton, A. (2008) Recent advances In the genetics of RA susceptibility. Rheumatology, 47, 399.
7. Buch, M. & Emery, P. (2002) The aethiology and pathogenesis of rheumatoid arthritis. Hospital Pharmacist, 9, 5.
8. Cantagrel, A., Navaux, F., Loubet-Lescoulie, P. et al. (1999) Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms. Arthritis and Rheumatism, 42, 1093.
9. Chung, F. (2001) Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-γ. Mediators of Inflammation, 10, 51.
10. Coakley, G., Mok, C.C., Hajeer, A.H. et al. (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and felty's syndrome. British Journal of Rheumatology, 37, 988.
11. Font, J., Garcia-Carrasco, M., Ramos-Casals, M. et al. (2002) The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjorgen's syndrome. Rheumatology, 41, 1025.
12. Grutz, G. (2005) New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. Journal of Leukocyte Biology, 77, 3.
13. Guzowski, D., Chandrasekran, A., Gaewl, C. et al. (2005) Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturating high-performance liquid chromatography. Journal of Biomolecular Techniques, 16, 154.
14. Hajeer, A.H., Lazarus, M., Turner, D. et al. (1998) Il-10 gene promoter polymorphisms in rheumatoid arthritis. Scandinavian Journal of Rheumatology, 27, 142.
15. Howell, W.M. & Rose-Zerilli, M.J. (2007) Cytokine gene polymorphisms, cancer susceptibility, and prognosis. Journal of Nutrition, 137, 194S.
16. Huizinga, T.W., Keijsers, V., Yanni, G. et al. (2000) Are differences in interleukin 10 production associated with joint damage. Rheumatology, 39, 1180.
17. Lacki, J.K., Klama, K., Porawska, W., Mickiewicz, S.H., Mulle, W. & Wiktorowicz, K. (1995) Interleukin 10 inhibits interleukin 6 production and acute phase response In rheumatoid patients. Archivum Immunologiae et Therapiae Experimentalis, 43, 11.
18. Le, T., leung, L., Carroll, W.L. & Schibler, K.R. (1997) Regulation of interleukin-10 gene expression: possible mechanisms accounting for its upregulation and for maturational differences in ist expression by blood mononuclear cells. Blood, 89, 4112.
19. Lindsay, J.O. & Hodgson, H.J. (2001) Review article: the immunoregulatory cytokine interleukin-10-a therapy for Crohn's disease? Alimentary Pharmacology and Therapeutics, 15, 1709.
20. MacKay, K., Milicic, A., Lee, D. et al. (2003) Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology, 42, 149.
21. Marionau, I., Healy, J., Mewar, D. et al. (2007) Association of Interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis and Rheumatism, 56, 2549.
22. Newton, J.L., Harney, S.M., Timms, A.E. et al. (2004) Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis and Rheumatism, 50, 2122.
23. Ollier, W. & Thomson, W. (1992) Population genetics of rheumatoid arthritis. Rheumatic Diseases Clinics of North America, 18, 741.
24. Opal, S.M. & DePalo, V.A. (2000) Anti-inflammatory cytokines. Chest, 117, 1162.
25. Padyukov, L., Hytonen, A.M., Smolnikova, M. et al. (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. Journal of Rheumatology, 31, 422.
26. Paradowska, A. & Lacki, J.K. (2006) Pro-inflammatory cytokines gene polymorphisms in rheumatoid arthritis. Central European Journal of Immunology, 31, 117.
27. Paradowska, A., Maslinskai, W., Grzybowska-Kowalczyk, A. & Lacki, J.K. (2007) The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Archivum Immunologiae et Therapiae Experimentalis, 55, 329.
28. Pawlik, A., Kurzawski, M., Gawronska-Szklarz, B., Herczynska, M. & Drozdzik, M. (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clinical Rheumatology, 24, 480.
29. Rashid, T., Tiwana, H., Wilson, C. & Ebringer, A. (2001) Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. IMAJ, 3, 675.
30. Reveille, J.D. (2005) Genetic studies in the rheumatic diseases: present status and implications for the future. Journal of Rheumatology, 32(Suppl. 72), 10.
31. Rindfleisch, J.A. & Mulle, D. (2005) Diagnosis and management of rheumatoid arthritis. Am Fam Physican, 72, 1037.
32. van Roon, J.A., Lafeber, F.P. & Bijlsma, J.W. (2001) Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis and Rheumatism, 44, 3.
33. Sangha, O. (2000) Epidemiology of rheumatic diseases. Rheumatology, 39(Suppl.2), 3.
34. Seng, H.C., Chyn, G.S., Naidu, R., Gupta, E., Somnath, S.D. & Radhakrishnan, A.K. (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Modern Rheumatology, 17, 429.
35. Silman, A. & Pearson, J.E. (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Research, 4(Suppl. 3), S265.
36. Williams, L.M., Ricchetti, G., Sarma, U., Smallie, T. & Foxwell, B.M. (2004) Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology, 113, 281.
37. Zdanov, A., Schalk-Hihi, C., Gustchina, A., Tsang, M., Weatherbee, J. & Wlodawer, A. (1995) Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon γ. Structure, 3, 591.
38. Zdanov, A., Schalk-Hihi, C. & Wlodawer, A. (1996) Crystal structure of human interleukin-10 at 1.6 a resolution and a model of a complex with its soluble receptor. Protein Science, 5, 1955.